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The Heart of New Ulm (HONU) Project is a community-based heart disease prevention intervention that delivers 
various component programs through health care, work sites, and the community. We examined the association 
between HONU program participation and blood pressure (BP) control over the first 2 years of the project.
Methods
The sample included residents aged 40 to 79 years from the target zip code who attended a heart health screening at 
baseline (2009) and again at follow-up (2011). BP control was defined as achieving or maintaining a BP less than 
140/90 mm Hg in 2011.
Results
BP improvements were observed in the sample: 81.7% of those who had controlled BP in 2009 maintained controlled 
BP 2 years later, and 52.4% of those with uncontrolled BP at baseline had controlled BP 2 years later (mean [SD] 
change in systolic BP, −10.6 mm Hg [20.8]). In the final adjusted model, participation in any 2 component programs 
of the HONU Project was associated with significantly higher odds of BP control among those with uncontrolled BP at 
baseline (n = 374). Participation in any component of the HONU Project among those with uncontrolled BP was 
associated with significant BP improvement compared with no participation.
Conclusions
The clinical, work site, and community education and behavioral programs (eg, healthful diet or physical activity) 
delivered as part of a population-level heart disease prevention intervention were associated with meaningful BP 
improvements over 2 years among those with uncontrolled BP at baseline.
Introduction
Cardiovascular disease (CVD) is the leading cause of death and disability among adults worldwide (1). Although the 
last few decades have seen a decrease in CVD mortality in the United States and many other countries (2), less 
progress has been made on reducing incident CVD in the upper midwestern United States (3). The rising prevalence of 
obesity and diabetes (4) coupled with higher prevalence of coronary heart disease (CHD) in rural areas (5) highlights 
the importance of reducing the burden of CVD risk factors in rural communities. High blood pressure (BP) is the most 
prevalent major CVD risk factor (nationally, 31% of men and 33% of women have high BP) (6) and shows few 
epidemiologic signs of abatement. High BP promotes atherogenesis, resulting in a twofold to threefold increase in CVD 
risk (7) and carries the highest population-attributable risk among CHD risk factors (8).
Descriptions of community-based initiatives designed to improve BP across a defined population are rare, particularly 
in rural areas. Only the Stanford Five-City project of 3 major US community-based CVD prevention studies achieved 
significant (4%) reductions in blood pressure over 5 years, mainly limited to women (9,10). More recently, a 
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WISEWOMAN community screening intervention program was successful in reducing high BP by 7% and 9% in 2 
intervention groups in Massachusetts (11).
In response to the gap in community-level CVD health improvement research, the Hearts Beat Back: The Heart of New 
Ulm (HONU) Project (www.heartsbeatback.org) was developed as a multi-year CVD prevention research and 
demonstration project serving rural New Ulm, Minnesota (12,13). The HONU Project implemented heart health 
screenings to assess risk factors in the target community. Various intervention programs were offered through the 
health care system, work sites, and the general community after baseline assessments. The objective of this analysis 
was to examine 2-year changes in BP in the target population and to assess the degree to which maintaining BP control 
among those with normal BP or achieving BP control among those with uncontrolled BP at baseline was associated 
with participation in HONU intervention programs (both numbers and types of programs).
Methods
Setting
New Ulm is about 100 miles southwest of the Minneapolis–St Paul, Minnesota, metropolitan area in an agricultural 
region of the state. The HONU Project, initiated in 2009, is a 10-year initiative primarily designed to target the 
approximately 7,900 adults aged 40 to 79 years who reside in the zip code that surrounds New Ulm (56073). The long-
term goal of the project is to reduce acute myocardial infarction rates and the short-term goal is to reduce the 
prevalence of 9 modifiable CVD risk factors (12,13). The HONU Project is a collaborative partnership of Allina Health, 
the Minneapolis Heart Institute Foundation, and the community of New Ulm. New Ulm Medical Center, an Allina-
owned hospital and clinic, is the primary health care service provider within the target population and a key 
organization in implementation of many HONU intervention programs.
The HONU Project is designed to implement evidence-informed health improvement practices, based on the 
community’s level of risk and preferences. To establish an understanding of the community’s level of risk, 
comprehensive heart health screenings, similar to those used in prior population-based prevention programs (14,15), 
were offered free to the community in 2009. These screenings served both as a needs assessment tool and as an 
intervention to educate residents on their risk factors and to offer health coaching around lifestyle changes and 
guidance for follow-up for managing medical conditions. Results from screenings identified high obesity rates, high 
prevalence of metabolic syndrome, low fruit and vegetable consumption, and low use of preventive medical therapies 
as interventions for priority risk factors (12,13).
HONU interventions are aligned with a social–ecological model of health determinants and health promotion 
addressing CVD risk factors at individual, social, institutional, community, and policy levels (16). Interventions are 
generally delivered through health care, work sites, and the general community by using best practices from previous 
interventions delivered in these contexts (17,18) (Appendix). Health care interventions include a health-care–based 
telephone coaching program for people at high risk for CVD, kiosks placed in the community to assess risk factors (ie, 
blood pressure and weight), and education of health care providers. Work site intervention programs targeted the 
community’s largest employers who were asked to implement wellness policies and health-related programs (eg, 
behavior change programs of 6 to 8 weeks focused on healthy eating and exercise for employees) and education 
programs for human resources managers on benefits planning, benefits design, and health promotion. Community-
wide interventions include social marketing focused on heart health improvement; health challenges focused on 
increased physical activity, fruit and vegetable consumption, and weight management; educational programs delivered 
to the community through various venues (eg, a local cooking television show, educational grocery store tours, an 
electronic and print newsletter, a website with education and program activity resources); a volunteer neighborhood 
leader program focused on community organizing around increased local health promotion activities; and 
environmental re-engineering efforts in the food environment (12,13).
Screening procedures
The heart health screening program was free to all people 18 years or older who presented in person at screening sites 
(eg, work sites, community centers, churches). As described in more detail elsewhere (12,13), the 2009 screenings were 
promoted to residents through letters, advertisements, work sites, and by health care providers at New Ulm Medical 
Center. Screenings ran from mid-April to mid-December 2009. The screening process was repeated in 2011 using 
similar methods. The Allina Institutional Review Board approved all procedures for the screenings and approved use 
of screening data for this study.
Screening participants were asked to fast 12 hours before their appointment. Screening lasted 20 to 30 minutes and 
included registration and consent, health history and behavioral risk factor survey, anthropometric measures (ie, 
height, weight, waist circumference, and blood pressure), and venipuncture. Participants were given a personal risk 
factor report and met with a health coach (ie, registered dietitian or health educator) to review risk factors, discuss 
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health improvement goals, and get guidance on community resources or other health education opportunities and 
referrals for any immediate medical follow-up.
Design and measures
This analysis used a longitudinal panel design. Data on people who were screened for CVD risk factors in both 2009 
and 2011 were included in the analysis. The primary outcome was BP in 2011, which was categorized as controlled 
(<140/90 mm Hg) or uncontrolled (≥140/90 mm Hg) based on the Fifth Report of the Joint National Committee 
(JNC) on Detection, Evaluation, and Treatment of High Blood Pressure (19) and in alignment with criteria used in 
other population studies (20,21). Although the Seventh JNC Report recommends a lower goal (130/80 mm Hg) for 
high-risk people such as patients with diabetes (22), a study among people with diabetes found no difference in 
outcomes based on the lower BP goal compared with a goal of less than 140/90 mm Hg (23).
Trained staff followed an adaptation of the Canadian Hypertension Society guidelines (24). They measured each 
participant’s BP using a SunTech 247 device (SunTech Medical, Morrisville, North Carolina) after sitting for 3 minutes. 
Three BP values were measured, taken 1 minute apart, using an automatic sphygmomanometer. The mean of the last 2 
BP measures was used for analytical purposes.
The main predictor was participation in a HONU intervention program between 2009 and 2011. Similar to methods 
used in previous large community CVD prevention projects (14), program participation was assessed by self-report 
during the 2011 screening with a single item where participants indicated which of 12 programs they participated in 
over the previous 2 years. Program participation was operationalized using 2 independent methods. First, 
participation was grouped into 5 categories based on program focus and delivery. These were 1) education — read at 
least 1 HONU newsletter (print or e-mail) or visited the HONU website; 2) physical activity — participated in the 
community health challenge or neighborhood walking program; 3) healthy eating — participated in at least 1 
neighborhood potluck, supermarket tour, or cooking class, or watched at least 1 episode of the HONU healthy cooking 
television show; 4) clinical — participated in the telephone coaching program or visited a heart health station at 1 of 4 
local sites; and 5) work site — participated in at least 1 work site wellness program. Second, to estimate total program 
exposure, the number of programs participated in by each participant was summed. Several baseline covariates were 
also included in analytical models based on their previously known or clinically suspected association with BP and 
program participation. These included age, sex, education level, smoking status, body mass index (BMI), personal 
history of diabetes or heart disease, and antihypertensive medication use at baseline.
Analysis
All analytical procedures were conducted using SAS (PC SAS 9.2, SAS Institute Inc, Cary, North Carolina). Means and 
standard deviations for continuous variables and percentages for categorical variables were described. Paired t tests 
and Bowker’s test of symmetry were used to assess changes in BP and medication use between 2009 and 2011. 
Multivariable logistic regression (PROC LOGISTIC) was used to examine the association between BP and program 
participation (modeled separately by program type as well as number of programs participated in). To gauge BP 
improvement versus maintenance of controlled BP, the analytical sample was stratified by those with controlled and 
uncontrolled baseline BP. Identical procedures were used for both analyses. First, a basic model was created to 
examine the crude relationship between program participation and BP. Then a full model was created with all 
covariate terms entered simultaneously. Screening participants who did not participate in any program was the 
comparison group for the analysis.
Results
A total of 3,123 participants in the target population were screened in 2009, of whom 1,455 (47%) returned for 
screening in 2011. Nine participants had missing BP data in 2011 and were excluded from further analyses. The final 
study sample of 1,446 represents 18% of all target area residents aged 40 to 79 years, per 2010 US Census estimates 
(25). Compared with those who did not return for screening in 2011, participants screened in both 2009 and 2011 were 
more likely to be women (63% vs 53.4%, P < .001) and were less likely to be obese (38% vs 43.3%, P < .001) or have 
high BP (25.9% vs 29.6%, P < .001). In addition, 96% were white, 35% had college or higher education, 99% were 
insured, and they had an average age (SD) of 56.3 (13.6) years.
Program participation
The educational programs had the greatest reach as 56.1% of participants had read at least 1 HONU newsletter and 
41.7% visited the HONU website (Table 1). Activities that included time commitments over several weeks such as the 
community health challenge and work site wellness programs had similar levels of participation (17%). Grocery store 
tours, cooking classes, and neighborhood programs had lower levels of participation with less than 10% participation 
rates in each. The controlled and uncontrolled baseline BP groups showed similar participation trends in 1, 2, or 3 or 
more programs. Overall, 77.5% of the study sample participated in at least 1 program. Program participants were more 
likely to have college or higher education (37% vs 29%, P = .01), to be women (69% vs 42.4%, P < .001), and less likely 
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to be obese (36% vs 45.1%, P = .003) or to have a self-reported history of heart disease or diabetes (9.25% vs 14.2%, P
= .01) at baseline compared with the 22% who did not participate in any program.
Blood pressure
During the 2009 baseline period, mean (SD) systolic/diastolic BP across the analytical sample was 127.8 (16.7)/76.5 
(9.9) mm Hg, and 25.9% of participants had uncontrolled BP. Antihypertensive medication was reported by 28.4% of 
participants at baseline. By the 2011 follow-up, systolic BP dropped by 2.9 (14.9) mm Hg, along with a 2.5 (8.5) mm Hg 
drop in diastolic BP (P < .001 for all changes). BP improvements were most pronounced among those with 
uncontrolled BP at baseline. Systolic and diastolic BP were reduced by 10.6 (20.8) and 6.5 (10.9) mm Hg 
(approximately 7%), respectively, with 52.4% of those with uncontrolled BP at baseline achieving BP control. Among 
those with controlled BP at baseline, 81.7% maintained their controlled BP status by 2011, with stable systolic BP and a 
small decrease of 1.1 (6.9) mm Hg in diastolic BP (Table 2).
Those with uncontrolled BP at baseline were also more likely to report use of antihypertensive medication (42.3% vs 
23.6% among those with controlled BP at baseline) (Table 2). The group with uncontrolled BP at baseline also 
experienced a larger increase in the use of medications between the 2 screenings.
Multivariable regression modeling found, among those with controlled BP in 2009, no significant association between 
the number of programs that were participated in and BP control in 2011 (Table 3). Similarly, no significant 
association was found between program type and BP control in 2011 among those with controlled BP at baseline (Table 
3). However, among those with uncontrolled BP in 2009, there was a significantly greater adjusted odds of controlled 
BP in 2011 for those who participated in 2 programs (odds ratio [OR], 2.45; 95% confidence interval [CI], 1.28–4.68) 
versus none. Furthermore, compared with those who did not participate in any program, participation in general 
educational (OR, 2.26; 95% CI, 1.32–3.85), clinical (OR, 2.60; 95% CI, 1.44–4.70), physical activity (OR, 2.70; 95% CI, 
1.36–5.37), healthy eating (OR, 1.94; 95% CI, 1.05–3.60) or work site (OR, 2.79; 95% CI, 1.33–5.85) programs showed 
an increased odds of BP improvement in 2011 (Table 3). Blood pressure medication use at baseline was not a 
significant covariate in any model.
Discussion
The trends in improved BP control over 2 years were encouraging in this sample, particularly among those with 
uncontrolled BP at baseline where systolic BP decreased by over 10 mm Hg and antihypertensive medication use 
increased by 14%. This level of improvement over 2 years was roughly equivalent to that observed in the US population 
over the previous 10 years (26). On the basis of pooled systolic BP and mortality associations from 5 large longitudinal 
population studies (27), an approximately 10 mm Hg reduction in systolic BP among those with high baseline BP 
would be expected to reduce CHD mortality by nearly 20% and stroke by nearly 30%. These findings are generally 
consistent with preliminary HONU Project analyses that have observed reduced occurrence of myocardial infarctions 
in the area (28).
The benefits of program participation were mixed. Among those with controlled baseline BP, program participation 
had little influence on the maintenance of BP control. Among those with uncontrolled baseline BP, however, 
participation in any program approximately doubled the odds of controlled BP over 2 years, with those who 
participated in 2 programs having the greatest chance of controlled BP relative to nonparticipants. All program types 
were beneficial for this group.
These findings create several implications for program design in the context of community-level CVD prevention 
initiatives. The benefits observed for those with uncontrolled baseline BP were least surprising because this group had 
the greatest near-term incentive to make health improvements. The fact that all program types were beneficial, 
however, was unexpected given the varying degrees of intensity in each, ranging from low-intensity programs (eg, 
newsletters and website) in general education programs to more intense didactic interactions with telephone coaches 
in the clinical program or short-term behavioral change programs delivered through work sites or the community. 
Explanations for this collective program success are unclear, but based on the general self-reported increase in 
antihypertensive medication use over time, program participants may have somehow experienced greater 
opportunities or openness to address BP control during medical encounters. The potential effect of the HONU Project 
on primordial hypertension control seems limited. BP was stable over 2 years in those with controlled baseline BP, and 
this finding was independent of direct program participation. Widespread participation in the neighborhood physical 
activity and healthy eating programs was not observed, but plans are under way to increase their reach because they 
have the potential to attract a broad cross-section of the population (including families with children) in other facets of 
CVD prevention (eg, lifestyle change).
There are several implications of these findings for health care providers in rural communities. First, health care 
organizations can be a lead partner for any prevention activities even if implemented through other venues such as 
work sites or for the general public. Provider referral for these programs may be an important part of recruitment and 
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retention. Additionally, the health care components may improve providers’ ability to address prevention through their 
clinical practice. For example, screening data on behavioral risk factors such as poor nutrition and lack of exercise can 
complement existing health record data since systematic measures of these patient-related factors are not typically 
available to providers. Providers can use this information to better counsel patients on these health risks, track 
changes, and tailor treatment.
The chief methodologic limitation of this study involved healthy volunteer bias, which is rarely accounted for in 
community-level research. The analytical sample in this study was composed of data on a subgroup of participants who 
were screened in both 2009 and 2011. However, our study participants represented about half of all screened 
participants and just 18% of the entire target population. Because those available for follow-up were generally healthier 
than those unavailable, the observed results may have limited generalizability to the entire community (ie, participants 
more inclined to get rescreened may have had a greater underlying propensity to benefit from the HONU Project). This 
hypothesis is somewhat supported by previous findings that people who are physically active and who have few 
lifestyle risk factors are more likely to be satisfied with preventive health care services (and are therefore more likely to 
participate in screenings or other such activities) (29). Self-reported program participation measures were also a 
limitation, but the objective measurement of BP was a strength, which was assessed several times at each screening 
visit by a trained professional using a calibrated SunTech 247 device in both years (30).
Among those with high BP at baseline, BP improved over 2 years, and this outcome was at least partially attributable to 
integrated prevention programs. Various program types seemed to benefit those with uncontrolled baseline BP, 
whereas most participants with controlled baseline BP had stable BP over the 2 years regardless of program 
participation. Further research is needed to determine the optimal suite of work site, clinical, and community-oriented 
programs that will have the greatest effect on primary and secondary CVD prevention.
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Tables
Table 1. Number and Category of Component Programs Used by Screened 
Participants Aged 40 to 79 Years, Stratified by Baseline Blood Pressure 










Baseline Controlled Blood Pressure 
(n = 1,072; 74.1%)
Baseline Uncontrolled Blood 
Pressure (n = 374; 25.9%)
1 Program 
(n = 203), 
%
2 Programs 




(n = 401), 
%
1 Program 











1.7 0.5 0.9 3.7 0 1.3 3.9
Cooking class 6.2 2.0 1.7 14.5 2.7 1.3 15.4
What’s Cooking New 
Ulm television show
21.6 8.4 21.4 38.2 8.0 23.4 52.3




4.9 1.5 1.7 13.7 0.0 1.3 6.2
Neighborhood 
lifestyle program
8.9 0.0 3.9 11.5 2.0 5.1 23.4
Health challenge 16.9 4.4 13.7 37.2 1.8 6.5 37.7
General education
Visited website 41.7 17.2 47.0 80.1 6.7 42.9 76.2




11.4 7.9 9.0 18.2 14.7 11.7 26.9
Heart health station 18.0 4.9 18.0 31.9 8.0 19.5 45.4
Work site
Work site wellness 
program
17.1 7.9 12.4 36.7 6.7 18.2 27.7
Overall 
participation in at 
least 1 program
77.5 78.2 75.4
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Table 2. Blood Pressure and Medication Use at Baseline Screening in 
2009 and Change From Baseline in 2011 for Participants Aged 40 to 
79 Years, The Heart of New Ulm Project, Minnesota
Status
Total, (N = 1,446)
Controlled Baseline Blood 
Pressure, (n = 1,072; 
74.1%)
Uncontrolled Baseline Blood 












































−2.5 (8.5) <.001 74.2 
(8.5)








Abbreviation: NA, not applicable.
P values are obtained from paired t test for continuous measures and categorical measures from Bowker’s test of 
symmetry.
This is the proportion of those with controlled blood pressure at baseline that had maintained control of blood pressure in 
2011 and the proportion of people who improved to controlled blood pressure among the group with uncontrolled blood 
pressure at baseline.
Table 3. Multivariable Association Between Program Participation, Type of 
Program, and Controlled Blood Pressure Among Participants Aged 40 to 79 




Baseline Controlled Blood Pressure (n 
= 1,072; 74.1%)
Baseline Uncontrolled Blood Pressure 
(n = 374; 25.1%)
OR (95% CI) P Value OR (95% CI) P Value
Program participation by number of programs (reference category is “no program participation”)
Model 1
1 program 1.06 (0.73–1.56) .75 1.24 (0.75–2.06) .41
2 programs 0.93 (0.59–1.46) .75 2.45 (1.28–4.68) .01
≥3 programs 1.65 (0.92–2.99) .09 1.54 (0.76–3.12) .23
Program participation by program type (reference category is “no program participation”)
Model 2
General education 1.19 (0.79–1.77) .41 2.26 (1.32–3.85) .002
Other types of programs 1.11 (0.64–1.93) .72 2.12 (1.03–4.40) .04
Model 3
Healthy eating program 1.29 (0.81–2.07) .29 1.94 (1.05–3.60) .03





a b a b
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Program 
Participation/Model
Baseline Controlled Blood Pressure (n 
= 1,072; 74.1%)
Baseline Uncontrolled Blood Pressure 
(n = 374; 25.1%)
OR (95% CI) P Value OR (95% CI) P Value
Model 4
Physical activity programs 1.47 (0.90–2.41) .12 2.70 (1.36–5.37) .004
Other types of programs 1.07 (0.72–1.60) .74 2.12 (1.25–3.60) .01
Model 5
Clinical program 1.12 (0.70–1.78) .64 2.60 (1.44–4.70) .002
Other types of programs 1.20 (0.79–1.81) .39 1.99 (1.14–3.48) .02
Model 6
Work site programs 1.07 (0.64–1.79) .80 2.79 (1.33–5.85) .01
Other types of programs 1.20 (0.80–1.79) .37 2.13 (1.25–3.61) .01
Abbreviations: OR, odds ratio; CI, confidence interval.
OR adjusted for baseline (2009) educational level, age, body mass index, disease history (diabetes or heart), blood 
pressure medication use, smoking, and sex in each model.
P values are Wald χ statistics from the logistic regression for number of program categories and component programs 
predicting blood pressure control in 2011.
Appendix. Heart of New Ulm (HONU) Project Intervention 
Programs Delivered Through the Community, Work Sites, 















coaching. Educate and coach 
individuals on their risk level 
and health behaviors. Held at 
work sites and public 
community locations over 6 






























1 day for individuals 










6 total health challenges 
offered to the community 
following broad campaign 
themes encouraging small 
changes in physical activity, 
nutrition, and stress 
management. Individual 









operations staff, and 
work site manager
Individual
a b a b
a
b 2










Cooking classes, grocery store 
tours, and presentations. 
“What’s Cooking New Ulm TV 
Show” is presented on local 
cable access 7 times per week 
with 64 new episodes in 2010 
and 2011.
Television show is 
weekly; grocery 
store tours last 1 
hour; cooking 
classes vary





New Ulm divided into 25 
districts with trained volunteer 
leaders who promote 
opportunities for exercise and 
healthy events such as a 
physical activity class, walking 












Works with restaurants, 
grocery stores and 
convenience stores to improve 














Telephone coaching program 
targeting patients at high 
cardiometabolic risk but 
without coronary heart 
disease. Goals: improve use of 
preventive medications and 
lifestyle-related risks. 
Integrated with primary care.
Individual Varies by individual 
(calls occur about 
every 4–6 weeks and 
last 15–30 minutes)
Dietitians, nurses, 
health care program 
manager
Grand rounds 9 HONU grand rounds 
educational events conducted 















Assessment of 46 local 
business wellness policies and 
environment. Results included 
recommendations to improve 
their work site wellness 
programs and policies.
Institutional/policy 1 session for 
assessment and 1 or 










29 companies. Reports given 
to each work site showing 
prevalence of risk factors 
among employees with 
recommendations for wellness 








Work site program 






Behavior change programs 
focused on weight loss, 
nutrition, or physical activity. 8 





6-8 weeks — level of 
individual or group 
activity varies by 
program






Annual employer summits with 
nationally recognized 
speakers, attended by 23–26 
companies. Five educational 
events offered through the 
chamber of commerce; 
attendance, 34–36 companies.
Institutional Varies depending on 
meeting (2 hours for 
summit, 1 hour for 
other events)
Work site program 
manager
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